TLR4 and hepatocellular carcinoma: Among others, blocking the lipopolysaccharide (LPS)- toll-like receptor 4 (TLR4) pathway, prevents the action of bowel-released bacterial products on the liver, and prevents the initiation and growth of HCC [3, 4].